loadpatents
Patent applications and USPTO patent grants for Wetzel; John M..The latest application filed is for "use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods".
Patent | Date |
---|---|
Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods App 20090318504 - Blackburn; Thomas P. ;   et al. | 2009-12-24 |
Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods Grant 7,465,750 - Blackburn , et al. December 16, 2 | 2008-12-16 |
Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods App 20070259942 - Blackburn; Thomas P. ;   et al. | 2007-11-08 |
Substituted alkyl amido piperidines Grant 7,199,135 - Marzabadi , et al. April 3, 2 | 2007-04-03 |
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods App 20070054910 - Konkel; Michael ;   et al. | 2007-03-08 |
3-imino-2-indolones for the treatment of depression and/or anxiety Grant 7,166,635 - Konkel , et al. January 23, 2 | 2007-01-23 |
Substituted alkyl amido piperidines Grant 7,105,544 - Marzabadi , et al. September 12, 2 | 2006-09-12 |
Substituted alkyl amido piperidines App 20060084649 - Marzabadi; Mohammad R. ;   et al. | 2006-04-20 |
Substituted Alkyl Amido Piperidines App 20060041139 - Marzabadi; Mohammad R. ;   et al. | 2006-02-23 |
Processes and polymorphs of diaryl-indolone galr3 antagonists App 20050192337 - Jubian, Vrej ;   et al. | 2005-09-01 |
4-aryl piperidines App 20050154022 - Marzabadi, Mohammad R. ;   et al. | 2005-07-14 |
4-Aryl piperidines App 20050154020 - Marzabadi, Mohammad R. ;   et al. | 2005-07-14 |
3-imino-2-indolones for the treatment of depression and/or anxiety App 20050148635 - Konkel, Michael ;   et al. | 2005-07-07 |
Substituted alkyl amido piperidines App 20040186103 - Marzabadi, Mohammad R. ;   et al. | 2004-09-23 |
Use of GAL3 antagonist for treatment of depression App 20040127502 - Blackburn, Thomas P. ;   et al. | 2004-07-01 |
GAL3 receptor antagonists for the treatment of affective disorders App 20040110821 - Konkel, Michael J. ;   et al. | 2004-06-10 |
Compounds specific for the human alpha1d adrenergic receptor and uses thereof App 20040106623 - Konkel, Michael ;   et al. | 2004-06-03 |
3-Imino-2-indolones for the treatement of depression and/or anxiety App 20040082615 - Konkel, Michael ;   et al. | 2004-04-29 |
Substituted alkyl amido piperidines App 20040073036 - Marzabadi, Mohammad R. ;   et al. | 2004-04-15 |
Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof Grant 6,706,716 - Konkel , et al. March 16, 2 | 2004-03-16 |
Compounds for the treatment of pain App 20030176314 - Forray, Carlos C. ;   et al. | 2003-09-18 |
Dihydropyridines and new uses thereof Grant 6,608,086 - Gluchowski , et al. August 19, 2 | 2003-08-19 |
Use of .alpha.1C specific compounds to treat benign prostatic hyperplasia Grant 6,602,888 - Gluchowski , et al. August 5, 2 | 2003-08-05 |
Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods App 20030078271 - Blackburn, Thomas P. ;   et al. | 2003-04-24 |
Compositions comprising alpha-1C specific compounds App 20030022900 - Gluchowski, Charles ;   et al. | 2003-01-30 |
Dihydropyridines and new uses thereof App 20020193599 - Gluchowski, Charles ;   et al. | 2002-12-19 |
Use Of Alpha-1c Specific Compounds To Treat Benign Prostatic Hyperplasia App 20020032219 - GLUCHOWSKI, CHARLES ;   et al. | 2002-03-14 |
Compounds specific for the human alpha1d adrenergic receptor and uses thereof App 20020028760 - Konkel, Michael ;   et al. | 2002-03-07 |
.alpha..sub.1C specific compounds to treat benign prostatic hyperplasia Grant 5,990,128 - Gluchowski , et al. November 23, 1 | 1999-11-23 |
Dihydropyridines and new uses thereof Grant 5,767,131 - Gluchowski , et al. June 16, 1 | 1998-06-16 |
Use of .alpha..sub.1C specific compounds to treat benign prostatic hyperlasia Grant 5,403,847 - Gluchowski , et al. April 4, 1 | 1995-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.